UNSPSC 51284609: Ertapenem disodium

This classification denotes a beta-lactam antibiotic C22H23N3O7S.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P5HEA33D9R, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3s,5s)-5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, sodium salt (1:2), (4r,5s,6s)-, but more generally known as ertapenem disodium, which bears US NIH Compound Identifier 150611. Most nations, for tariff and trade purposes, schedule ertapenem disodium under HS 29419000 and SITC 54139.

As of Q4 2014, ERTAPENEM DISODIUM remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4CCCC(C4)C(=O)[O-])C(=O)[O-])[C@@H](C)O.[NA+].[NA+].

UNSPSC 51284609 Ertapenem disodium is a Commodity code, but the recent state and local opportunities tagged under it show little direct activity in ertapenem procurement and instead reflect broader pharmaceutical supply and medical-supply contracting. The code nominally covers a single beta-lactam antibiotic, yet the opportunities in the dataset involve naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals through cooperative purchasing, and pharmacy benefit program management—none of which are ertapenem-specific. This mismatch suggests either inconsistent code assignment in state and local procurement systems or that the code serves as a catch-all for pharmaceutical and medical-supply categories rather than a discrete product line.

The issuing bodies include county health departments (Seminole County, Florida), city purchasing offices (Tampa), state health and human services agencies (Texas), and multistate cooperative purchasing alliances (Minnesota). Geographic activity is concentrated in Florida, Texas, and Minnesota, with multistate reach through the MMCAP cooperative. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (response due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and a SLBE set-aside designation (response due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (response due March 26, 2026). The code shows limited recent relevance to ertapenem specifically; firms pursuing pharmaceutical supply contracts under this code should verify that solicitations match their actual product or service lines before committing resources to pre-bid research or proposal development.